Brawn Biotech Live BSE/NSE | Brawn Biotech Fundamenta data | Brawn Biotech Balance sheet | Brawn Biotech Quarterly Results | Brawn Biotech Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6.83
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6.28
N/A
0.75

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

52.63
11.02
2.49

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
15.88
-1.16

PAT CAGR (%)

10 Years
5 Years
3 Years

10.73
36.56
-1.46

P:E (Median)

8 Years
5 Years
3 Years

10.77
11.58
8.88

P:BV (Average)

8 Years
5 Years
3 Years

0.80
0.80
0.80

EV:EBITDA (Average)

8 Years
5 Years
3 Years

3.60
3.32
-3.43

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 7 18 -58% 7 15 -57% 13 21 -38% 12 15 -21%
Expenses 8 17 -55% 7 16 -54% 13 21 -37% 11 14 -21%
EBITDA 0 1 - 0 0 - 0 0 -87% 0 0 -14%
EBIDTM -3% 4% -7% -2% 0% 2% 4% 3%
Other Income 0 0 -100% 0 1 -83% 0 0 0 0 0 -62%
Interest 0 0 -100% 0 0 0% 0 0 -50% 0 0 100%
Depreciation 0 0 0% 0 0 0% 0 0 0% 0 0 0%
PBT 0 1 - 0 0 - 0 0 -86% 0 1 -22%
Tax 0 0 -100% 0 0 - 0 0 -80% 0 0 -44%
PAT 0 1 - 0 0 - 0 0 -85% 0 0 -15%
PATM -3% 3% -5% 2% 0% 1% 3% 3%
EPS -0.72 1.79 - -1.08 1.02 - 0.12 0.87 -86% 1.14 1.32 -14%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 39 65 56 61 47 39 38 26 15 16 1 Net Sales Growth -44% 17% -8% 29% 21% 2% 46% 72% -7% 1,598% Cost Of Goods Sold 33 58 49 52 41 34 28 16 7 9 1 Gross Profit 6 7 7 8 6 5 10 9 8 7 0 GP Margin 15% 10% 12% 14% 14% 13% 25% 37% 55% 46% 15% Total Expenditure 39 64 54 59 45 38 37 25 15 16 1 Power & Fuel Cost - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Employee Cost - 3 3 2 2 2 3 4 4 4 0 % Of Sales - 5% 5% 3% 4% 4% 7% 16% 27% 24% 23% Manufacturing Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% General & Admin Exp. - 2 1 1 1 1 2 3 2 2 0 % Of Sales - 2% 2% 2% 3% 2% 4% 10% 14% 11% 6% Selling & Distn. Exp. - 1 1 1 1 2 5 1 2 1 0 % Of Sales - 1% 1% 2% 3% 5% 12% 6% 11% 7% 3% Miscellaneous Exp. - 0 0 3 0 0 0 1 0 0 0 % Of Sales - 0% 0% 4% 0% 0% 0% 2% 1% 1% 0% EBITDA 0 1 2 1 1 1 0 1 0 0 0 EBITDA Margin -1% 2% 4% 2% 3% 1% 1% 2% 2% 3% -20% Other Income 0 1 0 1 0 0 1 0 0 0 0 Interest 0 0 0 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0 0 0 0 PBT 0 2 2 2 1 0 1 1 0 0 0 Tax 0 0 1 0 0 0 0 0 0 0 0 Tax Rate -42% 26% 35% 20% 28% 40% 39% 39% 90% 49% -300% PAT 0 1 1 1 1 0 0 0 0 0 0 PAT before Minority Interest 0 1 1 1 1 0 0 0 0 0 0 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 0% 2% 2% 2% 2% 1% 0% 1% 0% 1% 51% PAT Growth -111% 4% -8% 46% 239% 100% -60% 1,650% -90% -56% EPS -0.53 4.43 4.27 4.63 3.17 0.93 0.47 1.17 0.07 0.70 1.60

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Net Sales

Net Sales Growth

-44%

17%

-8%

29%

21%

46%

72%

-7%

1,598%

Cost Of Goods Sold

Gross Profit

GP Margin

15%

10%

12%

14%

13%

25%

37%

55%

46%

15%

Total Expenditure

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

16%

27%

24%

23%

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

10%

14%

11%

Selling & Distn. Exp.

% Of Sales

12%

11%

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

-1%

-20%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

-42%

26%

35%

20%

28%

40%

39%

90%

49%

-300%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

51%

PAT Growth

-111%

-8%

46%

239%

100%

-60%

1,650%

-90%

-56%

EPS

-0.53

4.43

4.27

4.63

3.17

0.93

0.47

1.17

0.07

0.70

1.60

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 9 8 7 6 5 5 5 4 4 4 Share Capital 3 3 3 3 3 3 3 3 3 3 Total Reserves 6 5 4 3 2 2 2 1 1 1 Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 14 15 10 8 9 9 9 8 6 0 Trade Payables 10 11 7 5 7 7 7 5 4 0 Other Current Liabilities 2 2 2 2 1 2 2 3 1 0 Short Term Borrowings 0 0 0 0 0 0 0 0 0 0 Short Term Provisions 2 2 1 2 1 1 0 0 0 0 Total Liabilities 22 22 17 14 14 14 14 12 10 4 Net Block 0 0 0 0 0 0 0 0 0 0 Gross Block 0 0 0 0 0 0 0 0 0 0 Accumulated Depreciation 0 0 0 0 0 0 0 0 0 0 Non Current Assets 1 1 0 3 3 3 4 4 4 0 Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 Non Current Investment 0 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 1 1 0 3 3 3 4 4 3 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 22 22 17 11 11 11 10 9 6 4 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 0 0 0 0 1 2 2 3 2 0 Sundry Debtors 16 15 13 9 9 8 8 6 3 3 Cash & Bank 1 0 2 0 0 0 0 0 0 0 Other Current Assets 4 0 0 0 0 0 0 0 0 0 Short Term Loans & Adv. 4 6 1 1 0 0 0 0 0 0 Net Current Assets 8 7 7 3 2 2 1 1 1 4 Total Assets 22 22 17 14 14 14 14 12 10 4

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Shareholder's Funds

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 0 -2 1 0 0 0 0 0 0 0 PBT 2 2 2 1 0 0 1 0 0 0 Adjustment 0 0 2 0 0 0 0 0 0 0 Changes in Working Capital -1 -2 -2 -1 0 0 -1 0 0 0 Cash after chg. in Working capital 1 0 2 0 0 0 0 0 0 0 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -1 -1 -1 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 0 0 1 0 0 0 0 0 0 0 Net Fixed Assets 0 0 0 0 0 0 0 0 0 0 Net Investments 0 0 0 0 0 0 0 0 0 0 Others 0 0 1 0 0 0 0 0 0 0 Cash from Financing Activity 0 0 0 0 0 0 0 0 0 0 Net Cash Inflow / Outflow 0 -2 2 0 0 0 0 0 0 0 Opening Cash & Equivalents 0 2 0 0 0 0 0 0 0 0 Closing Cash & Equivalent 1 0 2 0 0 0 0 0 0 0

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Cash From Operating Activity

-2

PBT

Adjustment

Changes in Working Capital

-1

-2

-1

Cash after chg. in Working capital

Interest Paid

Tax Paid

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

Net Fixed Assets

Net Investments

Others

Cash from Financing Activity

Net Cash Inflow / Outflow

-2

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 29 25 23 18 16 16 15 14 14 13 ROA 6% 6% 9% 7% 2% 1% 3% 0% 3% 12% ROE 16% 18% 22% 18% 6% 3% 8% 1% 5% 13% ROCE 23% 28% 29% 26% 12% 8% 15% 6% 11% 3% Fixed Asset Turnover 181.72 156.34 178.97 166.98 216.79 341.50 254.30 229.14 708.71 80.18 Receivable days 88 92 67 72 83 79 95 109 76 1,248 Inventory Days 2 2 3 6 13 16 31 63 54 0 Payable days 63 62 39 49 68 68 102 129 47 56 Cash Conversion Cycle 27 32 31 28 28 27 23 42 83 1,192 Total Debt/Equity 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.01 0.00 0.00 Interest Cover 27 35 26 13 6 3 8 5 11 117

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Book Value (Rs.)

ROA

12%

ROE

16%

18%

22%

18%

13%

ROCE

23%

28%

29%

26%

12%

15%

11%

Fixed Asset Turnover

181.72

156.34

178.97

166.98

216.79

341.50

254.30

229.14

708.71

80.18

Receivable days

109

1,248

Inventory Days

Payable days

102

129

Cash Conversion Cycle

1,192

Total Debt/Equity

0.00

0.02

0.00

0.01

0.00

Interest Cover

117

Brawn Biotech Ltd.

Trading

BSE: 530207 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Brawn Biotech Ltd.

Trading

BSE: 530207 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update